Intensity Therapeutics, Inc.
USD4.10
+0.07 (+1.61%)
CEO
Lewis H. Bender
IPO Date
2023-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.96
Prev. Close
$4.04
Day Low
$3.93
Day High
$4.15
52W Low
$3.51
52W High
$43.50
Market Cap
$0.01B
Volume
0.16M
| 8,918 |
| $0.26 |
| 5 Jan 2026 | Talamo Joseph | Chief Financial Officer | A-Award | Acquired | 14,482 | $0.26 |
| 2 Jul 2025 | Wesolowski John M | Principal Accounting Officer | A-Award | Acquired | 69,745 | $0.26 |
| 2 Jul 2025 | Talamo Joseph | Chief Financial Officer | A-Award | Acquired | 14,179 | $0.26 |
| 6 May 2025 | DUBIN THOMAS I H | director | A-Award | Acquired | 50,000 | $0.57 |
| 6 May 2025 | Talamo Joseph | Chief Financial Officer | A-Award | Acquired | 300,000 | $0.57 |
| 23 Oct 2024 | Talamo Joseph | Chief Financial Officer | A-Award | Acquired | 427,379 | $3.44 |
| 15 May 2024 | DUBIN THOMAS I H | director | A-Award | Acquired | 50,000 | $4.42 |
| 15 May 2024 | DUBIN THOMAS I H | director: | Disposed | 0 | $0.00 |